Patent · US Expired

Topical and systemic treatment of psoriasis using 7-chloro-N-(3,4-dichlorophenyl)-2,3-dihydro-5-hydroxy-1-benzothiepin-4-c arboxamide 1,1-dioxide and pharmaceutically acceptable salts thereof

US4582850A · kind A · utility

1Cited by

1References

6Claims

0Family size

Assignee

Ciba-Geigy · US

Inventors

Hui L. Liauw · Morristown, US
Howard H. Oei · Berkeley Heights, US
Edmond Ku · Upper Saddle River, US

Key dates

Filing date	Feb 28, 1985
Grant date	Apr 15, 1986
Priority date	—
Expiry date	Feb 28, 2005

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Psoriasis is treated by the topical or oral administration of an effective endogenous lipoxygenase inhibiting amount of a compound of the formula ##STR1## and the pharmaceutically acceptable salts thereof to a patient in need of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.